Home / Going-concern warnings / InspireMD, Inc.
Filed 2025-08-04 路 Form 10-Q 路 Accession 0001641172-25-022040 micro
Price before filing: $2.69 (2025-08-01 close, split/dividend-adjusted)
Market cap at flag: $196.2M (2025-08-04) 路 Latest: $33.4M (2026-10-16)
| Window | NSPR | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -9.7% | +3.5% | -13.2% | 2025-09-03 |
| 90 days | -14.9% | +10.2% | -25.1% | 2025-11-03 |
| 180 days | -39.4% | +12.5% | -51.9% | 2026-02-02 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
90 days before the flag: 1 insider sold $38K (4 sales); 4 insiders bought $250K (4 purchases)
30 days after: none reported.
| Date | Insider | Type | Shares | Price | Value | 10b5-1 plan | Source |
|---|---|---|---|---|---|---|---|
| 2025-05-23 | Gleason Shane Thomas Chief Commercial Officer | Sale | 2,482 | $2.51 | $6K | no | Form 4 |
| 2025-05-27 | Gleason Shane Thomas Chief Commercial Officer | Sale | 1,572 | $2.51 | $4K | no | Form 4 |
| 2025-05-29 | Gleason Shane Thomas Chief Commercial Officer | Sale | 3,760 | $2.51 | $9K | no | Form 4 |
| 2025-05-30 | Gleason Shane Thomas Chief Commercial Officer | Sale | 7,186 | $2.51 | $18K | no | Form 4 |
| 2025-07-30 | Kester Thomas J Director | Purchase | 30,991 | $2.42 | $75K | no | Form 4 |
| 2025-07-30 | ROUBIN GARY S Director | Purchase | 41,322 | $2.42 | $100K | no | Form 4 |
| 2025-07-30 | Slosman Marvin CEO and President, Director | Purchase | 10,330 | $2.42 | $25K | no | Form 4 |
| 2025-07-30 | Stuka Paul Director | Purchase | 20,661 | $2.42 | $50K | no | Form 4 |
| 2025-08-04: red flag filed | |||||||
Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-05-06 to 2025-09-03. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.
"Therefore, there is substantial doubt about the Company's ability to continue as a going concern."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-06-30)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.